CareDx, Inc
CDNA
$12.03
$0.191.61%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.06% | 17.54% | 32.04% | 23.35% | 31.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.06% | 17.54% | 32.04% | 23.35% | 31.26% |
| Cost of Revenue | 2.35% | 9.57% | 10.01% | 12.39% | 8.16% |
| Gross Profit | -9.73% | 22.02% | 46.16% | 29.66% | 44.72% |
| SG&A Expenses | 0.10% | -8.43% | 32.71% | -7.34% | 2.47% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.16% | -2.03% | 17.74% | -2.40% | 2.92% |
| Operating Income | -47.00% | 64.49% | 19.98% | 63.16% | 72.33% |
| Income Before Tax | -88.76% | 48.45% | 166.29% | 69.41% | 81.61% |
| Income Tax Expenses | -631.82% | 169.88% | 3.64% | 350.00% | 132.35% |
| Earnings from Continuing Operations | -85.33% | 47.94% | 166.06% | 68.46% | 81.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -85.33% | 47.94% | 166.06% | 68.46% | 81.47% |
| EBIT | -47.00% | 64.49% | 19.98% | 63.16% | 72.33% |
| EBITDA | -86.28% | 76.45% | 22.13% | 71.71% | 83.41% |
| EPS Basic | -78.10% | 51.31% | 164.97% | 67.70% | 80.88% |
| Normalized Basic EPS | -74.05% | 76.89% | 9.49% | 70.88% | 80.12% |
| EPS Diluted | -77.78% | 50.61% | 160.76% | 67.70% | 80.58% |
| Normalized Diluted EPS | -74.05% | 76.89% | 15.65% | 70.88% | 80.12% |
| Average Basic Shares Outstanding | 4.04% | 6.91% | 1.68% | -2.35% | -3.07% |
| Average Diluted Shares Outstanding | 4.04% | 6.91% | 9.05% | -2.35% | -3.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |